secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2022-02-16T23:59:59+00:00
Accession:  0001157523-22-000208
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q4 rev $905.1M (+14.4%); reaffirms 2022 guidance with non-GAAP EPS $11.50-$11.75
--------------------------------------------------------------------------------

- Q4 GAAP EPS $2.67 vs $2.81 prior year (-5%); non-GAAP EPS $2.49 vs $2.39 (+4.2%).
- Full-year 2021 revenue $3.54B (+21.1%); organic growth 15.1%; non-GAAP EPS $10.32 (+26.9%).
- RMS segment organic growth 13.3%; DSA organic growth 6.7%; Manufacturing organic growth 21.2%.
- 2022 guidance: organic revenue growth 12.5-14.5%; non-GAAP EPS $11.50-$11.75; free cash flow ~$450M.
- GAAP net income Q4 $137.6M vs $143.2M; full-year $391M vs $364.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000115752322000208/0001157523-22-000208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000115752322000208/a52579962.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-000208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer